Citi Pharma (CPHL) highlights an ongoing uptrend within a structured channel, with key buying zones around PKR 92 and PKR…
Key takeaways Pakistan’s antibiotic market is valued at Rs185 billion, growing 12% YoY in FY25. CPHL is set to launch…
Citi Pharma (CPHL), one of Pakistan’s leading API producers, is gearing up for a major growth surge
Pakistan’s pharmaceutical sector witnessed significant growth in FY24, driven by price deregulation and rising demand for essential medications.
Citi Pharma Limited (CPHL) announced that it embraces solar energy, pioneering a sustainable path.
CPHL announced about a new venture for pharmaceutical innovation.